Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Community Dentistry and Oral Epidemiology
|
July 10, 2013
Predictors of coronal caries progression in adults: results from the Prevention of Adult Caries Study
Mabi Singh, Athena Papas, William Vollmer, et al.
Journal of the American Dental Association (1939)
|
October 2, 2014
Authors' response
John D Da Silva, Julie Kazimiroff, Athena Papas, et al.
Immunotherapy
|
November 7, 2025
Plain language summary: treatment of Sjögren's disease with dazodalibep
E William St Clair, Alan N Baer, Wan-Fai Ng, et al.
Journal of the American Dental Association (1939)
|
July 2, 2014
Outcomes of implants and restorations placed in general dental practices: a retrospective study by the Practitioners Engaged in Applied Research and Learning (PEARL) Network
John D Da Silva, Julie Kazimiroff, Athena Papas, et al.
ACS Measurement Science Au
|
February 23, 2026
Validation of Dried Saliva for Molecular Diagnostics
Andrea C Mora, Alexandra K Sogn, Allison J Tierney, et al.
ACS Measurement Science Au
|
October 20, 2025
A One-Pot RT-LAMP Diagnostic Assay for SARS-CoV‑2 from Saliva Samples
Andrea C Mora, Allison J Tierney, Alexandra K Sogn, et al.
Journal of Oral Science
|
April 3, 2012
Discovery of putative salivary biomarkers for Sjögren's syndrome using high resolution mass spectrometry and bioinformatics
Driss Zoukhri, Ian Rawe, Mabi Singh, et al.
Journal of Public Health Dentistry
|
February 11, 2012
Examiner training and reliability in two randomized clinical trials of adult dental caries
David W Banting, Bennett T Amaechi, James D Bader, et al.
Nature Medicine
|
June 5, 2024
CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial
E William St Clair, Alan N Baer, Wan-Fai Ng, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 18, 2024
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging Study
Thomas Dörner, Simon J Bowman, Robert Fox, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Community Dentistry and Oral Epidemiology
|
July 10, 2013
Predictors of coronal caries progression in adults: results from the Prevention of Adult Caries Study
Mabi Singh, Athena Papas, William Vollmer, et al.
Journal of the American Dental Association (1939)
|
October 2, 2014
Authors' response
John D Da Silva, Julie Kazimiroff, Athena Papas, et al.
Immunotherapy
|
November 7, 2025
Plain language summary: treatment of Sjögren's disease with dazodalibep
E William St Clair, Alan N Baer, Wan-Fai Ng, et al.
Journal of the American Dental Association (1939)
|
July 2, 2014
Outcomes of implants and restorations placed in general dental practices: a retrospective study by the Practitioners Engaged in Applied Research and Learning (PEARL) Network
John D Da Silva, Julie Kazimiroff, Athena Papas, et al.
ACS Measurement Science Au
|
February 23, 2026
Validation of Dried Saliva for Molecular Diagnostics
Andrea C Mora, Alexandra K Sogn, Allison J Tierney, et al.
ACS Measurement Science Au
|
October 20, 2025
A One-Pot RT-LAMP Diagnostic Assay for SARS-CoV‑2 from Saliva Samples
Andrea C Mora, Allison J Tierney, Alexandra K Sogn, et al.
Journal of Oral Science
|
April 3, 2012
Discovery of putative salivary biomarkers for Sjögren's syndrome using high resolution mass spectrometry and bioinformatics
Driss Zoukhri, Ian Rawe, Mabi Singh, et al.
Journal of Public Health Dentistry
|
February 11, 2012
Examiner training and reliability in two randomized clinical trials of adult dental caries
David W Banting, Bennett T Amaechi, James D Bader, et al.
Nature Medicine
|
June 5, 2024
CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial
E William St Clair, Alan N Baer, Wan-Fai Ng, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 18, 2024
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging Study
Thomas Dörner, Simon J Bowman, Robert Fox, et al.
Page
of 4